Evidence map›Paper›PMID 38066209›Full record

ArticleNature medicine2023

A toolkit for capturing a representative and equitable sample in health research.

Ameeta Retzer, Bircan Ciytak, Foram Khatsuria, Juma El-Awaisi, Isobel M Harris, Laura Chapman, Tony Kelly, Jenny Richards, Emily Lam, Philip N Newsome and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Nature medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Ameeta RetzerInstitute of Applied Health Research, University of Birmingham, Birmingham, UK. a.retzer@bham.ac.uk.ORCID 0000-0002-4156-8386
Bircan CiytakInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Foram KhatsuriaInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Juma El-AwaisiNIHR Birmingham Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.
Isobel M HarrisInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.ORCID 0000-0001-8125-3832
Laura ChapmanNIHR Birmingham Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.
Tony KellyNIHR Birmingham Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.
Jenny RichardsNIHR Birmingham Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.
Emily LamNIHR Birmingham Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.
Philip N NewsomeNIHR Birmingham Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.ORCID 0000-0001-6085-3652
Melanie CalvertInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.ORCID 0000-0002-1856-837X
NIHR Birmingham Biomedical Research Centre REP-EQUITY Group
NIHR Birmingham Biomedical Research Centre · GBUniversity Hospitals Birmingham NHS Foundation Trust · GBBritish Heart Foundation · GBHealth Data Research UK · GBNational Institute for Health Research · GBUniversity of Birmingham · GB

Funding

Medical Research Council MC_PC_21028
6 · The paper itself

Abstract

Research participants often do not represent the general population. Systematic exclusion of particular groups from research limits the generalizability of research findings and perpetuates health inequalities. Groups considered underserved by research include those whose inclusion is lower than expected based on population estimates, those with a high healthcare burden but limited research participation opportunities and those whose healthcare engagement is less than others. The REP-EQUITY toolkit guides representative and equitable inclusion in research. The toolkit was developed through a methodological systematic review and synthesis and finalized in a consensus workshop with 24 participants. The REP-EQUITY toolkit describes seven steps for investigators to consider in facilitating representative and equitable sample selection. This includes clearly defining (1) the relevant underserved groups, (2) the aims relating to equity and representativeness, (3) the sample proportion of individuals with characteristics associated with being underserved by research, (4) the recruitment goals, (5) the strategies by which external factors will be managed, (6) the methods by which representation in the final sample will be evaluated and (7) the legacy of having used the toolkit. Using the REP-EQUITY toolkit could promote trust between communities and research institutions, increase diverse participation in research and improve the generalizability of health research. National Institute for Health and Care Research PROSPERO identifier: CRD42022355391.

Indexed as

Delivery of Health CareResearch DesignHumans

Identifiers

PMID38066209
PMCPMC10719102
OpenAlexW4389487857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.